A carregar...

Combination Metronomic Oral Topotecan and Pazopanib: A Pharmacokinetic Study in Cancer Patients with Gynecological Cancer

BACKGROUND: Combination metronomic topotecan plus pazopanib is active against preclinical models of gynecologic cancer. Both agents are substrates for ATP-binding cassette family transporters so there is an increased likelihood for pharmacokinetic (PK) drug drug interactions. PATIENTS AND METHODS: P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Res
Main Authors: Turner, David C., Tillmanns, Todd D., Harstead, K. Elaine, Throm, Stacy L., Stewart, Clinton F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386652/
https://ncbi.nlm.nih.gov/pubmed/24023315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!